Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer

Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway

(2017) Dong Ren et al.   Molecular Cancer

Phospholipid Phosphatase 4 promotes proliferation and tumorigenesis, and activates Ca2+-permeable Cationic Channel in lung carcinoma cells

(2017) Xin Zhang et al.   Molecular Cancer

Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway

(2017) Dong Ren et al.   Oncotarget

Direct targeting sperm-associated antigen 9 by miR-141 influences hepatocellular carcinoma cell growth and metastasis via JNK pathway

(2016) Guohua Lou et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

N-cadherin promotes epithelial-mesenchymal transition and cancer stem cell-like traits via ErbB signaling in prostate cancer cells

(2015) MIN WANG et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

LDOC1 inhibits proliferation and promotes apoptosis by repressing NF-κB activation in papillary thyroid carcinoma

(2015) Shuiying Zhao et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Organ-specific adaptive signaling pathway activation in metastatic breast cancer cells

(2015) Riesa M. Burnett et al.   Oncotarget

Double-negative feedback loop between ZEB2 and miR-145 regulates epithelial-mesenchymal transition and stem cell properties in prostate cancer cells

(2014) Dong Ren et al.   CELL AND TISSUE RESEARCH

miR-141 Is a Key Regulator of Renal Cell Carcinoma Proliferation and Metastasis by Controlling EphA2 Expression

(2014) X. Chen et al.   CLINICAL CANCER RESEARCH

Loss of miR-100 enhances migration, invasion, epithelialmesenchymal transition and stemness properties in prostate cancer cells through targeting Argonaute 2

(2014) MIN WANG et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

Transforming growth factor-β promotes prostate bone metastasis through induction of microRNA-96 and activation of the mTOR pathway

(2014) M K Siu et al.   ONCOGENE

Recent insights into NF-κB signalling pathways and the link between inflammation and prostate cancer

(2013) Daniel P. Nguyen et al.   BJU INTERNATIONAL

CCN3 promotes prostate cancer bone metastasis by modulating the tumor–bone microenvironment through RANKL-dependent pathway

(2013) Po-Chun Chen et al.   CARCINOGENESIS

Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR-145

(2013) DONG REN et al.   INTERNATIONAL JOURNAL OF ONCOLOGY

HEF1 promotes epithelial mesenchymal transition and bone invasion in prostate cancer under the regulation of microRNA-145

(2013) Wei Guo et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Vascular endothelial cells facilitated HCC invasion and metastasis through the Akt and NF-κB pathways induced by paracrine cytokines

(2013) Yao-Hui Wang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Activation of NF-κB by the RANKL/RANK system up-regulates snail and twist expressions and induces epithelial-to-mesenchymal transition in mammary tumor cell lines

(2013) Masanobu Tsubaki et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The complexity of NF-κB signaling in inflammation and cancer

(2013) Bastian Hoesel et al.   Molecular Cancer

miRNA-141, Downregulated in Pancreatic Cancer, Inhibits Cell Proliferation and Invasion by Directly Targeting MAP4K4

(2013) Gang Zhao et al.   MOLECULAR CANCER THERAPEUTICS

TRAF2 is an NF-κB-activating oncogene in epithelial cancers

(2013) R R Shen et al.   ONCOGENE

Cancer statistics, 2012

(2012) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Circulating miRNAs as Surrogate Markers for Circulating Tumor Cells and Prognostic Markers in Metastatic Breast Cancer

(2012) D. Madhavan et al.   CLINICAL CANCER RESEARCH

Ubiquitination in signaling to and activation of IKK

(2012) Zhijian J. Chen   IMMUNOLOGICAL REVIEWS

Effect of Ulinastatin and Taxotere on growth inhibition, apoptosis of breast carcinoma cells is related to a decrease in signal conduction of JNk-2 and NF-kappaB

(2012) Hong Wang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms

(2012) Y-N Liu et al.   ONCOGENE

TRAF6 is an amplified oncogene bridging the RAS and NF-κB pathways in human lung cancer

(2011) Daniel T. Starczynowski et al.   JOURNAL OF CLINICAL INVESTIGATION

NF-kappaB in Lung Tumorigenesis

(2011) Zhenjian Cai et al.   Cancers

microRNA-141 is involved in a nasopharyngeal carcinoma-related genes network

(2010) Liming Zhang et al.   CARCINOGENESIS

MicroRNAs: Target Recognition and Regulatory Functions

(2009) David P. Bartel   CELL

MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets

(2009) Raffaele Baffa et al.   JOURNAL OF PATHOLOGY

Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma

(2009) Mara Compagno et al.   NATURE

Shared Principles in NF-κB Signaling

(2008) Matthew S. Hayden et al.   CELL